49:47

Addressing Purification Challenges for Complex Therapeutics with Custom Chromatography Resins

33:33

Shaken, Not Stirred Rocking Motion Versus Impeller Technology and What is Optimal

20:23

Grow Your CDMO With the Addition of Gloveless, Robotic Aseptic Filling

36:01

Flexible and Customized Approach to Lentiviral Vector Development and Manufacture

17:55

Product Quality in Focus

33:48

Streamline cGMP Viral Vector Analytical Challenges With Robust and Sensitive Impurity

22:33

WuXi Advanced Therapies Virology Operations: Cell & Gene Therapy Vector Regulatory Testing

22:30

High Performance With GMP Ready CHT Prepacked Process Scale Columns

27:14

Viral Clearance: A WuXi Advanced Therapies Perspective

45:21

Stability Assessment of mRNA Formulations – Toward the Development of Degradation Assays for mRNA

21:55

Leveraging NISTmAb Prior Knowledge to Demonstrate Analytical Competency

18:43

Next Generation PATfixTM Software

20:05

Screen Smarter Not Harder Expand and Accelerate Your Cell Line & Viral Vector Screening

30:24

Robust Methods for Stability and Identity Testing of Cell and Gene Therapies

31:15

Improve Your Cell Line Development Workflows with Analytical Tools

26:22

Enabling mRNA Based Therapeutics Development Through Efficient and Scalable mRNA Purification Method

28:28

Increasing Productivity of IVT Reaction Using At Line Monitoring by HPLC Chromatography

16:10

Streamlined AAV Manufacture From Plasmid Design to GMP Production

19:30

Small Format Connections for Optimizing Manufacturing

19:39

Less is More in mRNA Therapeutics Developing Big Ideas in Small Scale

10:37

Ensuring Leak Free Performance During Tissue Container Shipping Utilizing ASTM D4991

23:52

Robust and Scalable MAb Capture Facilitated by a Novel Convecdiff Membrane Structure

36:50

Sustaining Project Management Business Continuity and Partnerships Throughout COVID

18:15

The Critical Role of Cell Culture Media Analysis in Cell and Gene Therapies Development

24:14

Minimize Risk With Rapid At Line Concentration Measurement in Downstream Bioprocessing Applications

32:00

Moving Beyond PEI Improved Transfection Processes for AAV and LV Manufacture

13:06

Promoter Discovery for Optimized Viral Vector Development

35:06

Improving Gene Therapy Viral Vector Manufacturing Economics Modelling Bioprocess Costs

10:54

Ending CO2 Transmission Problems Using Purillex® Containers

19:12

Purification of DNA Oligonucleotides Using Anion Exchange Chromatography

20:10

Bioprocess Considerations for Large Scale Transfection

20:36

Best Practices in Mycoplasma Testing for Cell and Gene Therapies

29:44

Benefits of Hollow Fiber Filter Cell Expansion

19:55

Analytical Tools to Improve Production of Full Capsids in Initial Stages of AAV Process Development

49:47

Addressing Purification Challenges for Complex Therapeutics with Custom Chromatography Resins

20:01

A Flexible Intensified Seed Train to Boost Biopharma Productivity

23:44

Drug Discovery Screening Approaches for Rapid Assessment of Target Tractability

17:14

Downstream Process Development for the Purification of Biosimilar Insulin from Escherichia Coli

21:29

Development of LentiVEX™ Packaging and Producer Cell Lines for Lentivirus Manufacture

01:10:58

Developing Methods for Comparability Studies of Therapeutic Monoclonal Antibodies

12:29

Developing a Platform for Large Scale Lentiviral Manufacture

18:29

Continuity of Methods: Characterizing Protein Therapeutic Stability From Developability Assessment

35:48

Comprehensive Virus Clearance Evaluation Using Micro Scale Membrane Adsorbers

22:36

Bridging Anti CHO HCP Antibodies From Two Third Generation Cygnus CHO HCP ELISA Kits by AAE MS™

27:13

Accelerate Biologic Process Development and GMP Manufacturing

12:27

Improving Plasmid Design, Process and Manufacturing to Improve Viral Vector Yield

24:23

Manufacturing Capacity and Supply Chain Resilience

18:37

Scaling and Stirring: Success Factors in Scale Up with Single Use Benchtop Bioreactors

49:29

Cell Media Analysis: A Critical Piece of the Bioprocessing Puzzle

31:48

Efficient and Scalable GMP Manufacture of AAV and LV with TransIT VirusGEN® Reagent and Enhancers

20:21

Optimized Expression Systems for Increased Productivity in CHO DG44 Based Cell Line Development

13:56

Container Closure Integrity Testing of Bottles Used for Cell Therapy Applications

11:33

Analytical Ultracentrifugation for Profiling AAV Gene Therapies Where Are We Now?

16:40

Optimization of an Anion Exchange Method for the Large Scale Production of Plasmid DNA

18:03

Adenovirus Vector Manufacturing Platform Using CIMmultus QA

56:25

Practical Approaches to Metals Analysis of Cell Culture Media

48:34

Modernize Your Gene Therapy Analytics with Automated Tools from Bio Techne

34:29

Development of an Automated AAV8 Capsid Titer Assay on Gyrolab® xPand Immunoassay Platform

41:39

BioProcess Insider State of the Industry | December 2021 Panel Discussion

21:43

Scalable Lentiviral Vector Manufacturing Using Proprietary Suspension Cell Line